首页> 外文OA文献 >Transcription of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase type 3 gene, ATP2A3, is regulated by the calcineurin/NFAT pathway in endothelial cells
【2h】

Transcription of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase type 3 gene, ATP2A3, is regulated by the calcineurin/NFAT pathway in endothelial cells

机译:肌浆/内质网Ca2 + -ATPase 3基因ATP2A3的转录受内皮细胞中钙调神经磷酸酶/ NFAT通路的调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Histamine, known to induce Ca2+ oscillations in endothelial cells, was used to alter Ca2+ cycling. Treatment of HUVEC (human umbilical-vein endothelial cell)-derived EA.hy926 cells with histamine for 1–3 days increased the levels of SERCA (sarcoplasmic/endoplasmic reticulum Ca2+-ATPase) 3, but not of SERCA 2b, transcripts and proteins. Promoter-reporter gene assays demonstrated that this increase in expression was due to activation of SERCA 3 gene transcription. The effect of histamine was abolished by mepyramine, but not by cimetidine, indicating that the H1 receptor, but not the H2 receptor, was involved. The histamine-induced up-regulation of SERCA 3 was abolished by cyclosporin A and by VIVIT, a peptide that prevents calcineurin and NFAT (nuclear factor of activated T-cells) from interacting, indicating involvement of the calcineurin/NFAT pathway. Histamine also induced the nuclear translocation of NFAT. NFAT did not directly bind to the SERCA 3 promoter, but activated Ets-1 (E twenty-six-1), which drives the expression of the SERCA 3 gene. Finally, cells treated with histamine and loaded with fura 2 exhibited an improved capacity in eliminating high cytosolic Ca2+ concentrations, in accordance with an increase in activity of a low-affinity Ca2+-ATPase, like SERCA 3. Thus chronic treatment of endothelial cells with histamine up-regulates SERCA 3 transcription. The effect of histamine is mediated by the H1R (histamine 1 receptor) and involves activation of the calcineurin/NFAT pathway. By increasing the rate of Ca2+ sequestration, up-regulation of SERCA 3 counteracts the cytosolic increase in Ca2+ concentration.
机译:组胺,已知在内皮细胞中诱导Ca2 +振荡,被用来改变Ca2 +循环。 HUVEC(人脐静脉内皮细胞)衍生的EA.hy926细胞用组胺处理1-3天可增加SERCA(肌浆/内质网Ca2 + -ATPase)3的水平,但不会增加SERCA 2b,转录物和蛋白质的水平。启动子报告基因分析表明,表达的增加是由于SERCA 3基因转录的激活。组胺的作用被美吡拉胺消除,但西咪替丁没有,表明H1受体参与,但H2受体参与。组胺诱导的SERCA 3上调被环孢菌素A和VIVIT(一种阻止钙调神经磷酸酶和NFAT(活化的T细胞的核因子)相互作用)的肽消除,表明钙调神经磷酸酶/ NFAT通路参与其中。组胺还诱导NFAT的核易位。 NFAT并不直接与SERCA 3启动子结合,而是激活了Ets-1(E二十六个1),它驱动SERCA 3基因的表达。最后,根据组胺和低亲和力的Ca2 + -ATPase活性的增加(如SERCA 3),用组胺处理并装载呋喃2的细胞表现出更高的消除高钙质Ca2 +浓度的能力。因此,用组胺对内皮细胞进行长期治疗上调SERCA 3转录。组胺的作用是由H1R(组胺1受体)介导的,涉及钙调神经磷酸酶/ NFAT途径的激活。通过增加Ca2 +的螯合速率,SERCA 3的上调抵消了Ca2 +浓度的胞质增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号